跳至主要内容
临床试验/NCT01546792
NCT01546792已完成2 期

Effects of a Lifestyle Intervention on Quality of Life, Weight Loss and Cardiovascular Risk in Patients With Obstructive Sleep Apnoea Established on Continuous Positive Airway Pressure

Sheffield Teaching Hospitals NHS Foundation Trust4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
4
主要终点
Incremental shuttle walk performance

研究概览

简要总结

Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is a common disorder characterised by interrupted breathing while sleeping. It is associated with cardiovascular problems such as high blood pressure, heart attack and stroke. Furthermore, most patients with OSAHS are overweight and have impaired quality of life. Lifestyle interventions incorporating exercise training, dietary advice and behaviour change have been shown to elicit favourable changes in quality of life, body mass/composition and cardiovascular risk in a range of patient groups. However, no study has investigated the impact of lifestyle modification on such health outcomes in patients with OSAHS. This study will address this issue by investigating the effects of a lifestyle intervention on quality of life, body mass/composition and cardiovascular risk in patients with OSAHS. A total of 60 volunteers will be recruited and randomly allocated to one of the two groups. Patients in the intervention group will be offered a 12-week individualised lifestyle programme consisting of supervised exercise training, dietary advice and behaviour change counselling. Patients in the control group will receive an educational booklet detailing healthy eating and exercise guidelines but no supervised or structured intervention. The results of this study will inform the design of a larger, multi-centre randomised controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • obstructive sleep apnoea patients who have been receiving CPAP therapy for at least 6 months and are known to be adherent to the treatment (>75% nightly use per week)
  • clinically obese (body mass index >30)
  • age 18-85 years
  • able to undertake exercise testing and training

排除标准

  • patients with any contraindications to exercise (e.g. severe hypertension, unstable arrhythmias, severe musculoskeletal injuries)
  • unable to undertake the requirements of the study
  • non-English speaking
  • already undertaking >30 min exercise >3 times per week
  • non-compliant with CPAP
  • body mass index <30
  • unable to provide written informed consent

结局指标

主要结局

Incremental shuttle walk performance

时间窗: 25 weeks

Body mass

时间窗: 25 weeks

次要结局

  • Quality of life (EQ-5D and EQ-VAS)(13 and 25 weeks)
  • Body fat percentage(13 and 25 weeks)
  • Resting blood pressure(13 and 25 weeks)
  • Blood markers (glucose, insulin, lipids, CRP)(13 and 25 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Garry Tew

Senior Research Fellow

Sheffield Teaching Hospitals NHS Foundation Trust

研究点 (4)

Loading locations...

相似试验